)

Tenax Therapeutics (TENX) investor relations material
Tenax Therapeutics Cantor Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and market opportunity
Focused on Phase III development of an oral formulation for group two pulmonary hypertension (PH) patients with ejection fraction >40%.
Drug has a 25-year history and is approved in 60 countries for other indications.
U.S. heart failure population projected to grow from 6.7M in 2020 to 8.5M by 2030.
Addressable market for the target indication estimated at $10B, with no approved therapies currently.
Disease is progressive, debilitating, and often fatal, highlighting significant unmet need.
Scientific rationale and clinical development
Drug lowers elevated wedge pressure in heart failure patients, a key mechanism for symptom relief.
Phase II HELP trial demonstrated significant reduction in pulmonary wedge and right atrial pressures during exercise.
Mechanism of action attributed to reduction in preload and blood volume, not contractility.
Transition from IV to oral formulation was successful, supporting further development.
Legacy data and mechanistic studies provided confidence in safety and efficacy.
Phase III program design and progress
Ongoing Phase III trial (LEVEL) enrolling 230 subjects, with a 12-week primary endpoint focused on six-minute walk distance.
LEVEL 2 trial to start this year, expanding to 15+ countries and a 26-week endpoint.
Blinded sample size reassessment planned after 150 subjects complete treatment; FDA-approved cap on enrollment.
No new safety signals observed; high participation in open-label extension.
Enrollment for LEVEL expected to complete in the first half of next year.
Next Tenax Therapeutics earnings date

Next Tenax Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage